Association of suPAR, Galectin-3, and ST2 With CKD Progression in Heart Failure With Reduced Ejection Fraction

被引:0
|
作者
Roehm, Bethany A. [1 ]
Gordon, Jonathan [1 ]
McAdams, Meredith C. [1 ]
Xu, Pin [1 ]
Grodin, Justin [1 ]
Hedayati, Susan [1 ]
机构
[1] Univ Texas SouthWestern Med Ctr, Dallas, TX USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
SA-PO926
引用
收藏
页码:860 / 860
页数:1
相关论文
共 50 条
  • [1] SuPAR, Galectin-3 and ST2 Are Associated With Chronic Kidney Disease Progression in Patients With Heart Failure With Reduced Ejection Fraction
    Gordon, Jonathan S.
    Roehm, Bethany
    Xu, Pin
    McAdams, Meredith
    Grodin, Justin L.
    Hedayati, Susan
    CIRCULATION, 2022, 146
  • [2] Association of suPAR, ST2, and galectin-3 with eGFR decline and mortality in patients with advanced heart failure with reduced ejection fraction
    Roehm, Bethany
    McAdams, Meredith
    Gordon, Jonathan
    Zhang, Song
    Xu, Pin
    Grodin, Justin L.
    Hedayati, S. Susan
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 640 - 651
  • [3] Soluble ST2 and Galectin-3 and Progression of CKD
    Alam, Mariam L.
    Katz, Ronit
    Bellovich, Keith A.
    Bhat, Zeenat Y.
    Brosius, Frank C.
    de Boer, Ian H.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Hawkins, Jennifer J.
    Himmelfarb, Jonathan
    Kestenbaum, Bryan R.
    Kretzler, Matthias
    Robinson-Cohen, Cassianne
    Steigerwalt, Susan P.
    Tuegel, Courtney
    Bansal, Nisha
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (01): : 103 - 111
  • [4] Association of serum galectin-3 with depression in heart failure with reduced ejection fraction
    Alexanian, I.
    Parissis, J.
    Bistola, V.
    Bakosis, G.
    Thodi, M.
    Magiras, N.
    Pappas, L.
    Xydonas, S.
    Sideris, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 247 - 247
  • [5] Association of ST2, Galectin-3, and NT- Probnp in Elderly Hypertensive Patients and Heart Failure with a Preserved Ejection Fraction
    Li, Ping
    Wang, Lin
    Yang, Fan
    Yu, Hui
    Xiao, Fan Kai
    CURRENT VASCULAR PHARMACOLOGY, 2025,
  • [6] Soluble ST2 and Galectin-3 in Heart Failure
    Shah, Ravi V.
    Januzzi, James L., Jr.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (01) : 87 - +
  • [7] Galectin-3 in heart failure with preserved versus reduced ejection fraction
    Santhanakrishnan, R.
    Chong, J. P. C.
    Ng, T. P.
    Ling, L. H.
    Wong, R.
    Chai, P.
    Low, A. F.
    Ho, J. E.
    Richards, A. M.
    Lam, C. S. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S166 - S166
  • [8] Predictors of galectin-3 in patients with heart failure and reduced ejection fraction
    Alexanian, I.
    Parisis, I.
    Bistola, V.
    Bakosis, G.
    Cholevas, N.
    Tzifi, F.
    Karamichalakis, N.
    Niarchou, P.
    Xydonas, S.
    Pappas, L.
    Letsas, K.
    Efremidis, M.
    Sideris, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 561 - 561
  • [9] ST2 in heart failure with preserved and reduced ejection fraction
    Najjar, Emil
    Faxen, Ulrika Ljung
    Hage, Camilla
    Donal, Erwan
    Daubert, Jean-Claude
    Linde, Cecilia
    Lund, Lars H.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (01) : 21 - 27
  • [10] Prognostic value of galectin-3 in patients with heart failure and reduced ejection fraction
    Alexanian, I.
    Parisis, J.
    Bistola, V.
    Bakosis, G.
    Rizou, E.
    Magiras, N.
    Pappas, L.
    Xydonas, S.
    Efremidis, M.
    Sideris, A.
    Filippatos, G.
    EUROPEAN HEART JOURNAL, 2018, 39 : 580 - 580